Group 1 - The company completed the acquisition of 52.0006% equity in Shan'en Kang Biotechnology (Suzhou) Co., Ltd. on April 7, 2024 [2] - Following the acquisition, shareholder Yu Xueping will transfer 1% of the equity held on behalf of Ling Zhenjing to Ling Zhenjing, as per the agreement [2] - The name of the shareholder "Dongtai Liyue Enterprise Management Center (Limited Partnership)" has been changed to "Shanghai Shanhe Liyue Enterprise Management Center (Limited Partnership)" [2] Group 2 - Shan'en Kang has completed the industrial and commercial change registration and obtained a new business license from the Kunshan Data Bureau [2] - The registered capital of Shan'en Kang is 87.292808 million yuan, and it was established on September 29, 2016 [2] - The business scope includes technology consulting, food production, sales of household appliances, and import-export business [2]

Core Viewpoint - Jiangsu Zeyu Biotechnology Co., Ltd. has been established with a registered capital of 10 million yuan, focusing on various advanced biotechnologies and medical research [1] Company Summary - The legal representative of Jiangsu Zeyu Biotechnology Co., Ltd. is Zhang Jian [1] - The company's business scope includes cell technology research and application, human stem cell technology development and application, medical research and experimental development, natural science research and experimental development, and human genetic diagnosis and treatment technology development [1] - Zeyu Intelligent (301179) is among the shareholders of Jiangsu Zeyu Biotechnology Co., Ltd. [1]